Fumitaka Suzuki

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi et al. · Hepatology · 2012 · 700 citations · Full text

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—A prospective randomized study of hepatitis C virus-related liver cancer

Kenji Ikeda, Yasuji Arase, Satoshi Saitoh et al. · Hepatology · 2000 · 357 citations · Full text

Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma

Yusuke Kawamura, Yasuji Arase, Kenji Ikeda et al. · The American Journal of Gastroenterology · 2011 · 277 citations

Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

Norio Akuta, Fumitaka Suzuki, Hitomi Sezaki et al. · Intervirology · 2005 · 268 citations

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

Norio Akuta, Fumitaka Suzuki, Yusuke Kawamura et al. · Journal of Hepatology · 2006 · 266 citations

Hepatology, Hepatitis C, Viral Hepatitis +10